The U.S. Department of Defense has awarded BrainScope a $4.5 million research contract to create and integrate ocular capabilities into its handheld, multi-parameter mild traumatic brain injury (mTBI) and concussion products.
The Bethesda, Md.-based company’s initial product, BrainScope One, is the first FDA-cleared medical device that can assess the full spectrum of brain injury – from concussions (functional abnormality) to brain bleeds (structural injury). BrainScope One uses EEG and other parameters to help the clinician to reach a diagnosis. With this research contract, BrainScope will add specific capabilities to assess the patient’s eyes. These features will be incorporated in future versions of BrainScope’s products, according to a company statement.